Equity
€1.4m ▲ 0.4%
Dr RAHAL paid out €126,823 in dividends. That is 95% of the 2025 profit.
Dr RAHAL
Lifetime
20 annual accounts with figures on one time axispeak €374,550 (2017)
€353,112▲ 61.0%
peak €204,387 (2015)
€133,088▲ 707%
peak €1.6m (2022)
€1.4m▲ 0.4%
€223,505▲ 79.8%
Board3 names since 2017
3 directorsRAHAL Michel and 2 others
Documentsfilings and deeds
18-05-202618 days late
2025micro format
Gross margin from €219,296 to €353,112Result from €16,498 to €133,088Appointment: Igne Parmentier (director) 30-01Dividend €126,823Debts from €124,283 to €223,505Cash from €92,688 to €187,624
Key points
from the 2025 annual accountsResult
€133,088 ▲ 707%
The result rose in 2025 from €16,498 to €133,088.
Turnover
≈ €710,000 estimated
The micro format states no turnover.
Debts
€223,505 ▲ 79.8%
Debts rose by €99,222 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Investments
€207,658 2.6 × depreciation
Green is investment, beige is depreciation.
Filings
20 annual accounts since 2006
Eight of the last ten came late. The 2018 accounts came latest: 19 days after the end of the period.
Checked score
95
Excellent
Financially stronger than 63% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.3%▲ +0.2 percentage points vs 04-2026highest value
06-2026: < 0.1%▼ -0.3 percentage points vs 05-2026lowest value
07-2026: < 0.1%● unchanged vs 06-2026lowest value
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%▲ +0.1 percentage points vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
No registered site in the KBO
lowers risk
Size: total assets €1.7m
Equity €1.4m (86.5% of total assets)
Figures for financial year 2025 (filed on 18-05-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 59% on liquidity, 61% on profitability and 50% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-09-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 20,137 companies had the same profile as Dr RAHAL has now. Each dot stands for 51 companies, two years later.
95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
That fits the bankruptcy probability of Dr RAHAL itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for Dr RAHAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €130,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.23 (1.74 in 2024), below the usual 1.5. Short-term debt is 13.4% and cash 11.3% of total assets. 13.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 18 days late
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 18-05-2026, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
18 days late
2024
1 day early
2023
10 days late
2022
14 days late
2021
13 days late
2020
18 days late
2019
12 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 12 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 13 May (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-09-2026 year end10-11-2026 today30-04-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0877273740
Appointment: Igne Parmentier (director)
General meeting of 30-12-2024 · Gazette deed
Company renamed from DOCTEUR ANTOINE RAHAL to Dr RAHAL
Change of role: RAHAL Antoine, from manager to director · Appointment: RAHAL Michel (director) · Director discharge: RAHAL Antoine (manager) · General meeting of 15-11-2023 · Gazette deed
Registered office moved from Liège to Chaudfontaine
New registered office: rue des Muguets, n° 15, 4052 CHAUDFONTAINE (Beaufays) · Previous registered office: rue des Guillemins 72/11 4000 LIEGE · Partner: Antoine RAHAL (associé unique) · General meeting of 15-11-2019 · Gazette deed
Official details
Source: KBO- Status
- Active since 15-11-2005Normal situation
- Activity
- “L’exercice de la médecine par le ou les actionnaires qui la composent,lesquels sont exclusivement…” (deed in French)From the articlesNo NACE code in the KBO yet
- Financial year end
- 30 September
- Peppol
- Reachable since 09-12-2025
Insights on Dr RAHAL
Dr RAHAL files the micro format. That format states no turnover. The gross margin rose from €210,663 in 2006 to €353,112 in 2025.
The balance sheet grew most from 2010 to 2012 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr RAHAL
- What is the company number of Dr RAHAL?
- The company number of Dr RAHAL is 0877.273.740. The VAT number is the same number with BE in front: BE 0877.273.740.
- Where is Dr RAHAL based?
- The registered office is at Rue des Muguets 15, 4052 Chaudfontaine.Company details
- What is the legal form of Dr RAHAL?
- Dr RAHAL is a private limited company (BV).
- When was Dr RAHAL founded?
- Dr RAHAL was founded on 15-11-2005.
- Is Dr RAHAL still active?
- Yes, Dr RAHAL is an active enterprise in the KBO register.
- What is the turnover of Dr RAHAL?
- The turnover in financial year 2025 is ≈ €710,000. This figure is estimated from the gross margin of €353,112 and 878 comparable companies of the same size. It probably lies between €490,000 and €1.0m. It is a rough estimate.Financials
- Is Dr RAHAL profitable?
- In financial year 2025, Dr RAHAL made a profit of €133,088.
- Where can I find the annual accounts of Dr RAHAL?
- Dr RAHAL filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr RAHAL due?
- Dr RAHAL must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.